![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
100 episodes
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
touchPODCAST touchpodcast
-
- Science
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.
Educating physicians on a fully global scale since 2005!
We make positive changes to clinical practice, with the ultimate objective of improving patient and community health.
Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates
Home of:
- touchONCOLOGY
- touchENDOCRINOLOGY
- touchOPHTHALMOLOGY
- touchNEUROLOGY
- touchCARDIOLOGY
- touchINFECTIOUSDISEASES
- touchIMMUNOLOGY
- touchRESPIRATORY
- touchHAEMATOLOGY
- touchDERMATOLOGY
This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
-
Intracranial haemorrhage related to direct oral anticoagulant medications Latest evidence for reversal strategies
touchTALKS for touchNEUROLOGY
A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition.
The expert
Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchneurology.com -
Intracranial haemorrhage related to direct oral anticoagulant medications: Latest evidence for reversal strategies
touchTALKS for touchCARDIO
A thrombosis and haemostasis expert shares insights into reversal strategies for patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH), including benefits and risks of DOAC use, evidence for DOAC reversal agents and guideline-directed management of the condition.
The expert
Prof. Dr. med. Jan Beyer-Westendorf, University Hospital Carl Gustav Carus, Dresden, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchCARDIO.com -
touchMDT – Impact of pharmacotherapies for achondroplasia – Discussion 4
touchMDT for touchENDOCRINOLOGY
Listen to experts Prof. Karin Blakemore, Prof. Klaus Mohnike, Prof. Janet Legare and patient advocate Carly Kutner provide their insights on the impact of pharmacotherapies for achondroplasia
The multidisciplinary team and patient advocate:
MFM specialist - Prof. Karin BlakemoreJohns Hopkins University School of Medicine, Baltimore, MD, USA
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany
Paediatrician - Prof. Janet LegareUniversity of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Patient advocate - Ms Carly KutnerFreehold, NJ, USA
This touchPODCAST is for HCPs only.This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/ -
touchMDT – Monitoring and early treatment initiation - Discussion 3
touchMDT for touchENDOCRINOLOGY
Listen to experts Prof. Janet Legare and Prof. Klaus Mohnike, plus patient advocate Carly Kutner, explore the importance of monitoring and early treatment initiation in achondroplasia to reduce the risk of paediatric complications
The multidisciplinary team and patient advocate:
Paediatrician - Prof. Janet LegareUniversity of Wisconsin School of Medicine and Public Health, Madison, WI, USA
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany
Patient advocate - Ms Carly KutnerFreehold, NJ, USA
This touchPODCAST is for HCPs only.This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/ -
touchMDT – Early recognition of achondroplasia – Discussion 2
touchMDT for touchENDOCRINOLOGY
Listen to experts Prof. Janet Legare, Prof. Karin Blakemore, Prof. Klaus Mohnike and patient advocate Carly Kutner explore the importance of early recognition of achondroplasia in reducing the risk of paediatric complications.
The multidisciplinary team and patient advocate:
Paediatrician - Prof. Janet LegareUniversity of Wisconsin School of Medicine and Public Health, Madison, WI, USA
MFM specialist - Prof. Karin BlakemoreJohns Hopkins University School of Medicine, Baltimore, MD, USA
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany
Patient advocate - Ms Carly KutnerFreehold, NJ, USA
This touchPODCAST is for HCPs only.This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/ -
touchMDT – MDT management of achondroplasia – Discussion 1
touchMDT for touchENDOCRINOLOGY
Listen to key experts Prof. Klaus Mohnike, Prof. Karin Blakemore and Prof. Janet Legare discuss the multidisciplinary management of achondroplasia, including the importance of appropriate specialist referrals
The multidisciplinary team:
Paediatric endocrinologist - Prof. Dr. med. Klaus Mohnike Otto-von-Guericke University Magdeburg, Magdeburg, Germany
MFM specialist - Prof. Karin BlakemoreJohns Hopkins University School of Medicine, Baltimore, MD, USA
Paediatrician - Prof. Janet LegareUniversity of Wisconsin School of Medicine and Public Health, Madison, WI, USA
This touchPODCAST is for HCPs only.This activity is funded by an unrestricted independent medical education grant from BioMarin Pharmaceutical Inc. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchendocrinologyime.org/mdt-diagnosis-monitoring-early-treatment-in- achondroplasia/